Stock market announcement archive

February 27, 2024
Bergen, Norway, February 27th, 2024: Today, Lifecare AS (LIFE) (the “Company”), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), publishes Q4 financial report and operational update. Lifecare holds steady a course towards the upcoming automated pilot production. The first three quarters of 2023, Lifecare reported on huge achievements both […]
Read more
February 28, 2023
Bergen, Norway 28 February 2023Today Lifecare publish Q4 2022 interim report. The consolidated group financials show a revenue in Q4 of 5.31 MNOK, compared to1,6 MNOK in Q4 2021. The unaudited interim figures for 2022 show a revenue of20,7 MNOK compared to 1,6 MNOK in 2021. The report is attached to this releaseand are also […]
Read more
April 21, 2022
Bergen, Norway 21 April 2022Today, Lifecare 2021 annual report is published. 2021 was marked by severalimportant milestones: o Regulatory approval for first-in-human pilot clinical trials o Restructuring the organization - controlling development operationso Reinforced Patent Protection and IPo Successful Capital IncreaseThe report is subject to approval by the company's general meeting on 6 May2022.Lifecare AS' […]
Read more
April 20, 2021
Lifecare publiserer i dag årsmelding med årsregnskap for 2020. Rapportene ergjenstand for godkjenning i selskapets generalforsamling 7. mai 2021. Spørsmål kan rettes til: Joacim Holter, CEO Tel: +47 40 05 90 40E-mail: joacim.holter@lifecare.attme.dev
Read more
April 20, 2021
Lifecare is today publishing its annual report with accounts for 2020. Thereports are subject to approval by the company's general meeting on 7 May 2021.For more information, please contact: Joacim Holter, CEOPhone: +47 40 05 90 40Email: joacim.holter@lifecare.attme.dev
Read more